Dr. Rakhmanina is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
111 Michigan Ave Nw
Washington, DC 20010Phone+1 202-884-2182- Is this information wrong?
Education & Training
- University of Kansas School of MedicineFellowship, Allergy and Immunology, 1996 - 1997
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 1993 - 1996
- The Peoples' Friendship University of Russia Faculty of MedicineClass of 1988
Certifications & Licensure
- DC State Medical License 2002 - 2024
- OH State Medical License 2000 - 2004
- AR State Medical License 1995 - 2003
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents Start of enrollment: 2004 Nov 01
- Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort Start of enrollment: 2011 Jan 01
Roles: Contact
- Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance Start of enrollment: 2022 Jun 30
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsPharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV:...Carina A Rodriguez, Eva Natukunda, Renate Strehlau, Esme L Venter, Supattra Rungmaitree, Coleen K Cunningham, Umesh Lalloo, Pope Kosalaraksa, Elizabeth HellstrÖm, Afaa...> ;The Lancet. HIV. 2024 May 1
- Are we ready for long-acting HIV treatment for adolescents?Natella Rakhmanina> ;The Lancet. HIV. 2024 Apr 1
- Experiences of adolescents and youth with HIV testing and linkage to care through the Red Carpet Program (RCP) in Kenya.Kose, J., Howard, T., Lenz, C., Masaba, R., Akuno, J., Woelk, G., Fraaij, P., Rakhmanina, N.> ;Plos One. 2024 Jan 1
- Join now to see all
Press Mentions
- AAP Updates Guidance on HIV Testing and Prophylaxis in YouthDecember 20th, 2021
- PEDIATRICS on Call: Research Roundup with Dr. Lewis First; Dealing with HIV in the Pediatric PopulationDecember 1st, 2020
Grant Support
- Effect Of Puberty On The Phamacokinetics Of Efavirenz In Hiv-Infected ChildrenEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2011
- Pharmacokinetics Of Lopinavir Crushed Versus Whole Tablets: HIVNational Center For Research Resources2010
- Effect Of Puberty On The Pharmacokinetics Of Efavirenz In Hiv-Infected ChildrenNational Center For Research Resources2010
- Optimizing Antiretroviral Therapy In Hiv-Infected Children And AdolescentsNational Center For Research Resources2006–2010
- Pharmacokinetics Of Lopinavir Crushed Versus Whole TabletsNational Center For Research Resources2009
Professional Memberships
- Fellow
Hospital Affiliations
- Children's National HospitalWashington, District of Columbia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: